Heron Therapeutics Inc

NASDAQ:HRTX  
8.39
-0.14 (-1.64%)
Products

Heron Therapeutics Announces FDA Approval Of A Significant Indication Expansion For Zynrelef®

Published: 12/09/2021 13:17 GMT
Heron Therapeutics Inc (HRTX) - Heron Therapeutics Announces FDA Approval of a Significant Indication Expansion for Zynrelef®.
Heron Therapeutics - is Continuing to Study Zynrelef in Additional Procedures With Plans to Submit a Second Snda to FDA in Second Half of 2022.